KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Cash (2017 - 2025)

Guardant Health (GH) has disclosed Change in Cash for 9 consecutive years, with -$200.1 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 241.39% to -$200.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$140.3 million through Dec 2025, up 72.15% year-over-year, with the annual reading at -$140.3 million for FY2025, 72.15% up from the prior year.
  • Change in Cash hit -$200.1 million in Q4 2025 for Guardant Health, down from -$46.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $676.3 million in Q4 2023 to a low of -$358.3 million in Q2 2022.
  • Historically, Change in Cash has averaged -$17.2 million across 5 years, with a median of -$31.3 million in 2022.
  • Biggest five-year swings in Change in Cash: crashed 616.41% in 2022 and later soared 4158.59% in 2023.
  • Year by year, Change in Cash stood at -$340.4 million in 2021, then skyrocketed by 95.1% to -$16.7 million in 2022, then skyrocketed by 4158.59% to $676.3 million in 2023, then tumbled by 108.67% to -$58.6 million in 2024, then plummeted by 241.39% to -$200.1 million in 2025.
  • Business Quant data shows Change in Cash for GH at -$200.1 million in Q4 2025, -$46.0 million in Q3 2025, and -$68.4 million in Q2 2025.